Industry: Manufacturing (SIC 2836 — Biological Products, (No Diagnostic Substances))
Of the 1,000 filings in this window, 20 (2.0%) are routine debt or shelf offerings (form 424B*, FWP, S-3*), which are excluded from the routine rate below because large issuers generate them continuously.
| Form type | Filings in window |
|---|---|
| 4 | 560 |
| 144 | 89 |
| 8-K | 88 |
| 3 | 30 |
| SC 13G/A | 29 |
| 10-Q | 26 |
| SC TO-T/A | 18 |
| SC 13G | 16 |
| SC TO-C | 14 |
| CT ORDER | 14 |
| SCHEDULE 13D/A | 10 |
| DEFA14A | 10 |
| SCHEDULE 13G/A | 9 |
| DEF 14A | 9 |
| Metric | Value |
|---|---|
| Window covered | 2018-03-13 → 2026-10-02 |
| Span | 8.55 years |
| All filings in window | 1,000 |
| Routine filings (offerings excluded) | 980 |
| Routine filings per year | 115 |
| Insider forms as share of routine filings | 59.0% |
| Routine debt/shelf offering share | 2.0% |
Former names on record: GILEAD SCIENCES INC
| Field | Value |
|---|---|
| CIK | 0000882095 |
| Tickers | GILD |
| Exchange | Nasdaq |
| State of incorporation | DE |
| Fiscal year end | 1231 |
| Filer category | Large accelerated filer |
Raw EDGAR source for this entity: submissions/CIK0000882095.json · EDGAR filings list